GlassScriptPhysician profile
Suzanne Peplinski
NPI 1265617872
$483.50
in general payments reported to CMS, 2019-2025
10 companies · $61.76 in 2025
The $61.76 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.70 · 2020: $54.31 · 2022: $45.20 · 2023: $117 · 2024: $117 · 2025: $61.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $173.56 | 2023-2025 | Azstarys |
| Alk-Abello, INC | $81.32 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Cranial Technologies, INC | $51.47 | 2019-2025 | Doc Band |
| Tris Pharma INC | $50.31 | 2019 | |
| Kaleo, INC. | $34.30 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.79 | 2020-2022 | |
| Verrica Pharmaceuticals INC. | $19.87 | 2023 | Ycanth |
| Sanofi Pasteur INC. | $18.43 | 2020 | |
| Aimmune Therapeutics, INC. | $12.90 | 2022 | |
| Ironshore Pharmaceuticals INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Peplinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.